DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award
GRANTS.GOV Due: August 27, 2025 at 12:00 AM UTC
In-Active Grant

Summary

The DOD Amyotrophic Lateral Sclerosis (ALS) Therapeutic Development Award is a grant opportunity aimed at supporting innovative research and development projects that focus on therapeutic solutions for ALS. This initiative is particularly suited for academic institutions, research organizations, and companies engaged in biomedical research and drug development. Contractors and businesses that possess expertise in neurology, pharmacology, and related fields are encouraged to apply, as the goal is to advance the understanding and treatment of ALS through novel therapeutic approaches. The award seeks to foster collaboration and innovation in the fight against this debilitating disease, making it a critical opportunity for those dedicated to improving patient outcomes.
Funding Information